AFA

NEWS:

• Antibiotics ‘double bleeding risk’ in warfarin...
• Dabigatran increased bleeding, embolic complicatio...
• Doctors to run campaign against heart disease...
• Atrial fibrillation topic of free lecture on Feb....
• La Comisión Europea aprueba Rivaroxaban, el antic...
• Noticias Feasan La ablación por cirugía mínimam...
• Hidden Afib Common in Stroke of Unknown Cause...
• Apixaban Works in Afib Even With Prior Stroke...
• Are erratic heartbeats tied to unexplained strok...
• London 2012: Rower Tom James treated for Atrial Fi...
• Bright Medical Joins Blood Pressure Battle...
• First Patient Enrolled in Medtronic-Supported Head...
• Single atrial fibrillation ablation procedure achi...
• New AF ablation consensus document previewed at sy...
• New AF ablation consensus document previewed at sy...
• Dronedarone gets another chance to prove itself in...
• Pan-European Stroke Prevention In Atrial Fibrillat...
• Key to stroke prevention: better use of blood thin...
• New AF ablation consensus doc previewed at Boston...
• Atrial Fibrillation Ablation in the Real World --...
• NURSE PRACTITIONER (MSN)- Cardiac Arrhythmia Servi...
• All about dronedarone, from ATHENA to PALLAS...
• AF following TAVI associated with higher risk of s...
• Antiarrhythmics for Atrial Fibrillation: Practical...
• Biotronik study shows Home Monitoring benefits for...
• Study points to personal treatment for atrial fibr...
• Government and Health Providers Must Act Now to Pr...
• Better heart treatment could avert thousands of st...
• Quality of Life Up in Obese A-Fib Patients Post-Ab...
• UK NICE approves apixaban for DVT prevention...
• Circ: Colchicine reduces incidence of AF after car...
• Obesity Predicts Higher Quality of Life Outcomes i...
• Apixaban Superior to Warfarin for Atrial Fibrillat...
• Leading Heart Advocates Launch AFib Task Force in...
• Abstract 16443: Development of a New Risk Stratifi...
• Anticoagulants aid vascular treatment...
• PRIVATE PRACTICE WITH DR SETH BILAZARIAN...
• Study: Xarelto Cuts Heart Attack Mortality...
• Atrial Fibrillation Keeping the beat: Living with...
• PALLAS Trial Demotes Dronedarone for AF...
• AHA:Afib Stroke Risk follows Heart Transplant...
• Radiofrequency ablation feasible in paroxysmal AF...
• FDA approves rivaroxaban in for stroke prevention...
• Afib Ablation Boosts Kidney Function...
• Xarelto (Rivaroxaban) Approved By FDA For Non-Valv...
• J&J Wins Blockbuster Approval to Market Xarelto fo...
• Dose Selection of New Oral Anticoagulants in Patie...
• FDA broadens approval of J&J's Xarelto for patient...
• Late Night Report: PCI With Stents and Atrial Fibr...
• New drug promising for patients with stroke risk...
• Mayo Clinic Heart Specialists Use Cold Therapy to...
• Atrial fibrillation goes unnoticed in over 65s...
• FDA advisers reject Medtronic heart device...
• What can I do?...
• New drug promising for patients with stroke risk...
• Around 20,000 Canadians Suffer Cardiac Arrest Ever...
• Treating AF during pregnancy...
• Echocardiographic diastolic parameters and risk of...
• Sanofi Heart Drug Restricted After Organ Injuries...
• Rivaroxaban (Xarelto) Gets Positive Recommendation...
• HFSA: Statins Tied to Lower Mortality in Afib...
• Penn Study Indicates Atrial Fibrillation May Be Ro...
• Barry Manilow Urges Americans to "Get Back in Rhyt...
• FDA Advisory Panel Backs Xarelto to Prevent Stroke...
• AFA Calls for Urgent Action to Prevent Impending S...
• ESC: Older Afib Patients Tolerate Anticoagulants...
• New Atrial Fibrillation in Primary Care (AFIP) Too...
• ESC: Apixaban beats out warfarin for preventing st...
• How Can We Avoid a Stroke Crisis in Latin America?...
• Atrial Fibrillation: Managing the At-Risk Stroke P...
• The Paris review: ARISTOTLE, dal-VESSEL, and PURE...
• Warfarin anti-clotting drug may be safe for elderl...
• Apixaban vs. Warfarin for Prevention of Stroke and...
• Don't be afraid: very old patients treated with Vi...
• Patient Case Series: A Female Patient With Atrial...
• Apixaban vs rivaroxaban vs dabigatran vs warfarin...
• ARISTOTLE: The birth announcement of apixaban into...
• Apixaban shines in ARISTOTLE; dalcetrapib and HDL...
• ESC President highlights congress' 'international...
• ESC: Anticoagulants Top Meeting Agenda...
• ESC: Apixaban Better than Warfarin at Preventing S...
• Pradaxa® (Dabigatran Etexilate) Revolutionizes St...
• Boehringer Ingelheim to Launch RE-ALIGN(TM) Trial...
• Examining The Causes of Atrial Fibrillation...
• The determinants of stroke phenotypes were differe...
• Heart Patient Gets a Novel Wave of Laser Surgery...